Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals


Injectable Buprenorphine Resources

Buprenorphine Extended-Release Implementation Guide
This comprehensive guide outlines key components for the successful implementation of buprenorphine extended-release injection for the treatment of opioid use disorder. It covers relevant definitions, identifies regulatory bodies, and highlights educational resources and tools to ensure regulatory compliance while providing high-quality patient care.
Download file

Boston Medical Center Injectable Buprenorphine Protocols
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 42-50. These guidelines should be used to inform the administration of injectable buprenorphine at Boston Medical Center.
Visit webpage

Consent for Treatment with Injectable Buprenorphine

Haitian Creole

Extended-Release Buprenorphine: An Instructional Guide

Initiation of Monthly Injectable Buprenorphine
Guidance for starting a patient on monthly injectable buprenorphine, including required preparation and injection day planning. This is not meant to replace clinical decision-making.
Visit webpage

Injectable Buprenorphine Administration Checklist
Checklist for injectable buprenorphine administration. Please reference the 2021 "Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse" document, pages 62-63.
Visit webpage

Lidocaine Administration Prior to LAIB Injection Protocols | Boston Medical Center
Boston Medical Center's Policy and Procedure Manual's Standing Order for Administration of Lidocaine prior to Injection of Long Acting Injectable Buprenorphine (LAIB).

Injectable Lidocaine Administration
Topical Lidocaine Administration

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.

© 2024 Boston Medical Center. All rights reserved. Site by Root802.